The status of the mixing and matching of coronavirus disease (COVID-19) vaccines was provided by the Department of Science and Technology (DOST) through its weekly report of accomplishments. File Photo / Unsplash DOST’s Philippine Council for Research and Development (DOST-PCHRD) reported through...
More than 300 participants of the country’s “Mix and Match” (MnM) study have already received their first dose of Sinovac vaccine, the Department of Science and Technology (DOST) said Friday, Jan. 7. (Photo by Robyn Beck/AFP/FILE PHOTO/MANILA BULLETIN) The 18 month-long study seeks to...
A total of 90 participants of the country’s “Mix and Match” (MnM) study have already received their first dose of vaccines against coronavirus disease (COVID-19), the Department of Science and Technology (DOST) said Friday, Dec. 10. (MANILA BULLETIN FILE) DOST Undersecretary for Research and...
The Department of Science and Technology (DOST) has logged more than 40 participants in the country’s “Mix and Match” (MnM) study. (MANILA BULLETIN FILE) The 18 month-long study seeks to evaluate the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and...
The government’s coronavirus disease (COVID-19) vaccine “mix and match” trial was launched in Muntinlupa City on Monday, Nov. 22. According to the Muntinlupa City government, the Department of Science and Technology (DOST), through the Philippine Society for Allergy, Asthma, and Immunology...
The country’s P240-million “Mix and Match” (MnM) study seeking to evaluate the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults is expected to be rolled out in in Muntinlupa City next week, the Department of Science...
The Department of Science and Technology (DOST) is eyeing 3,000 participants for the coronavirus disease (COVID-19) vaccine mix-and-match trials. (JUAN CARLO DE VELA / MANILA BULLETIN) In his weekly report, DOST Secretary Fortunato de la Pena said DOST is seeking 3,000 volunteers aged 18 years old...
The Philippine Food and Drug Administration (FDA) has approved on Nov. 17 the country's coronavirus disease (COVID-19) vaccine mix-and-match trials, the Department of Science and Technology (DOST) announced Friday, Nov. 19. (ALI VICOY / MANILA BULLETIN) In a Laging Handa briefing, DOST...
The Department of Science and Technology (DOST) said Friday, Nov. 12, that the recruitment of 3,000 participants for the country’s “Mix and Match” (MnM) study has yet to start. (MANILA BULLETIN FILE) DOST Undersecretary for Research and Development Dr. Rowena Cristina L. Guevara said they...
The Department of Science and Technology (DOST) expressed hope Wednesday, Nov. 10, that the Food and Drug Administration (FDA) will soon give its go signal for the conduct of the “Mix and Match” (MnM) trial which seeks to determine the safety and immunogenicity of mixing different coronavirus...
The Philippines will likely start by end of this month or early November its “Mix and Match” trial or MnM study to determine the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults. (MANILA BULLETIN FILE PHOTO) DOST...
The Philippines’ study on the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults may start soon. (MANILA BULLETIN FILE PHOTO) During his weekly report on Friday, Oct. 22, Department of Science and Technology (DOST)...
